Clinical Trials in Georgia

Showing 8841-8860 of 19,050 trials

Chronic Total Occlusion Percutaneous Coronary Intervention Study

NCT03988166

The objective of this study is to evaluate angiographic confirmation of placement of any guidewire beyond the CTO, in the true vessel lumen, in patients undergoing CTO percutaneous coronary intervention (PCI) in which at least one Teleflex guidewire and at least one Turnpike catheter are used.

Chronic Total OcclusionIschemic Heart DiseaseChronic Total Occlusion of Coronary Artery

Vascular Solutions LLC150 participantsStarted May 2020

Torrance, California, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +10 more locations

TERMINATEDPhase 165 miles

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

NCT03218683

This study is a multicenter, open-label, nonrandomized, sequential group, dose-escalation study to assess safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ascending doses of AZD5991 in subjects with relapsed or refractory hematologic malignancies Part 1 of the study is monotherapy dose escalation. Closed November 2020 Part 2 of the study is monotherapy expansion groups for relapsed/refractory chronic lymphocytic leukaemia (CLL), AML/ myelodysplastic syndromes (MDS), and multiple myeloma (MM). Closed November 2020 Part 3 is a sequential, dose-escalation study of the combination of AZD5991 and venetoclax in subjects with relapsed/refractory AML

Relapsed or Refractory Acute Myeloid Leukemia (AML)

AstraZeneca70 participantsStarted Aug 2017

Orange, California, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +7 more locations

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

Find Trials by Condition in Georgia

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.

Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration

Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing

A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Dysport® Adult Upper Limb Spasticity

Dysport® Adult Lower Limb Spasticity Study

A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD